First Time Loading...

Mesoblast Ltd
ASX:MSB

Watchlist Manager
Mesoblast Ltd Logo
Mesoblast Ltd
ASX:MSB
Watchlist
Price: 1.155 AUD 6.45% Market Closed
Updated: May 6, 2024

Wall Street
Price Targets

MSB Price Targets Summary
Mesoblast Ltd

Wall Street analysts forecast MSB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MSB is 1.635 AUD with a low forecast of 0.808 AUD and a high forecast of 2.741 AUD.

Lowest
Price Target
0.808 AUD
30% Downside
Average
Price Target
1.635 AUD
42% Upside
Highest
Price Target
2.741 AUD
137% Upside
Mesoblast Ltd Competitors:
Price Targets
VITR
Vitrolife AB
31% Upside
9966
Alphamab Oncology
62% Upside
300149
ChemPartner PharmaTech Co Ltd
182% Upside
GMAB
Genmab A/S
36% Upside
VYGR
Voyager Therapeutics Inc
105% Upside
KRTX
Karuna Therapeutics Inc
2% Downside
ALGEN
Genoway SA
62% Upside
048530
iNtRON Biotechnology Inc
139% Upside

Revenue
Forecast

Revenue Estimate
Mesoblast Ltd

For the last 8 years the compound annual growth rate for Mesoblast Ltd's revenue is -11%. The projected CAGR for the next 3 years is 151%.

-11%
Past Growth
151%
Estimated Growth
Estimates Accuracy
-18%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Mesoblast Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss

Net Income
Forecast

Net Income Estimate
Mesoblast Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MSB's stock price target?
Price Target
1.635 AUD

According to Wall Street analysts, the average 1-year price target for MSB is 1.635 AUD with a low forecast of 0.808 AUD and a high forecast of 2.741 AUD.

What is Mesoblast Ltd's Revenue forecast?
Projected CAGR
151%

For the last 8 years the compound annual growth rate for Mesoblast Ltd's revenue is -11%. The projected CAGR for the next 3 years is 151%.